Chlorite In The Treatment Of Neurodegenerative Disease


The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or multiple sclerosis (MS) in a subject by administering chlorite in an amount effective to decrease blood immune cell activation. The invention also features methods of monitoring therapy by assessing blood immune cell activation before and after therapy.

Download PDF
Document Preview
Document History
  • Publication: Jun 14, 2016
  • Application: Apr 27, 2012
    US US 201213458954 A
  • Priority: Apr 27, 2012
    US US 201213458954 A
  • Priority: Oct 7, 2010
    US US 90036110 A
  • Priority: Mar 17, 2006
    US US 37898706 A
  • Priority: Jan 24, 2005
    US US 4281605 A
  • Priority: Feb 3, 2004
    US US 54157604 P

Download Citation

Sign in to the Lens